Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- Advertising (246)
- Medicines safety (146)
- COVID-19 (144)
- Prescription medicines (129)
- Regulatory compliance (120)
- COVID-19 vaccines (88)
- Legislation (78)
- Therapeutic goods regulation (71)
- Listed medicines (48)
- Non-prescription medicines (43)
- Medical devices safety (42)
- Safety (40)
- Vaping hub (33)
- Complementary medicines (30)
- Manufacturing (28)
- Assessed listed medicines (24)
- Labelling and packaging (22)
- Over the counter (OTC) medicines (21)
- Compliance and enforcement hub (20)
- Medicinal cannabis hub (20)
- Scheduling (national classification system) (20)
- Import and export (19)
- Australian Register of Therapeutic Goods (ARTG) (17)
- Alert/Advisory (12)
- Shortages (12)
- In Vitro Diagnostic medical devices (IVDs) (11)
- Sunscreens (6)
- Weight loss products (6)
- Advisory bodies and committees (5)
- Cosmetics (3)
- Blood and blood components (2)
- Clinical trials (2)
- Fees and payments (2)
- Prescription opioids hub (2)
- Unique Device Identification (UDI) hub (2)
- Blood safety (1)
- Breast implant hub (1)
- Registered complementary medicines (1)
- Travelling with health products (1)
Results for
"[search-keyword]"
Search
1052 result(s) found, displaying 851 to 875
-
NewsCommonly asked questions about stem cells and regulation
-
Media releasesInfringement notice issued for the alleged advertising of a cancelled therapeutic good
-
Media releasesInfringement notice issued for the alleged advertising of Schedule 4 substances
-
NoticesNew requirements for caffeine and caffeine-containing ingredients within listed medicines
-
NoticesAn amendment to the Therapeutic Goods (Permissible Ingredients) Determination commenced on 2 September 2019.
-
BlogWhen a company makes a medicine, quality is planned for with Good Manufacturing Practice.
-
Safety updatesMedicines Safety Update article
-
-
NewsAre you aware of the risks associated with cosmetic injections?
-
Media releasesUpdate on amendments to the Therapeutic Goods Advertising Code (No.2) 2018 and medicines advertising pre-approval
-
Media releasesThe TGA has commenced work on a sector-wide compliance activity relating to the advertising of bioresonance devices
-
NoticesDirection Notice issued to cease advertising of therapeutic goods not entered in the ARTG
-
NoticesDirection Notice issued to cease advertising of unregistered therapeutic goods to consumers
-
-
Safety updatesSafety information: regulators review balloon and stent devices used to unblock blood vessels in the legs
-
NewsThe TGA will not pursue the development of an alternative quality standard for sunscreen excipient ingredients at this time in 2019.
-
Media releasesAn individual has been fined for the alleged importation of unapproved cosmetic products after returning from an overseas trip to China
-
Media releasesInfringement notices issued for the alleged importation and advertising of unapproved performance and image enhancing products
-
NewsInformation for consumers on the use of performance and image enhancing drugs
-
Media releasesInformation on how supplements are regulated in Australia
-
NewsChanges will be made to the regulation of nappy rash products on 1 January 2020
-
Media releasesImprovements to Consumer Medicine Information
-
Media releasesImportant information about the dangers of using thermography for breast cancer detection
-
Media releasesThe Federal Court has imposed substantial penalties on Peptide Clinics Australia
-
Media releasesRisks associated with cosmetic injections can be related to both the product and the experience of the person performing the procedure